ClinicalTrials.gg
Drug

Siltuximab clinical trials

Also written CNTO 328 and Sylvant.

studies test it
38
open now
7
in phase 3
3
first study started
2003

How each study uses siltuximab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the siltuximab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Apr 2014 · SYLVANT · BLA 125496 (FDA, Drugs@FDA)
European Union
22 May 2014 · Sylvant · EMEA/H/C/003708 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Siltuximab
31
Anti-IL-6 Chimeric Monoclonal Antibody
4
cCLB8
3

Brand

Sylvant
9

Development codes

CNTO 328
14

Studies by the year they started

37 studies that test it; most in 2011 (4)

Studies that test siltuximab, by start year
YearStudies
20031
20052
20063
20071
20081
20092
20102
20114
20122
20163
20171
20203
20212
20234
20242
20254

Who runs them

Industry 18 · Other 20

Centocor, Inc. (8) · Janssen Research & Development, LLC (7) · Memorial Sloan Kettering Cancer Center (2) · SWOG Cancer Research Network (2) · Recordati UK (2) · Nantes University Hospital (1) · University of Alabama at Birmingham (1) · Timothy Voorhees (1)

Often tested with

Tested in the same studies.

Interleukin 1 Receptor Antagonist Protein (1) · Tocilizumab (1) · Anti-IL-6 Monoclonal Antibody (1) · Erenumab (1) · Epcoritamab (1) · Teclistamab (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test siltuximab.

Studies

Open first, then newest update. How each study uses siltuximab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 38

See all 38 studies that test siltuximab →

Given beside what is tested · 4 — siltuximab is usual care or a partner of the new treatment

Codes

What other systems call siltuximab · ClinicalTrials.gg INT004818

  • MeSH (NLM) C504234siltuximabConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) T4H8FMA7IMSILTUXIMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1535218Confirmed FDA, Wikidata
  • Wikidata Q3960572siltuximabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61084SiltuximabOne source FDA
  • DrugBank DB09036One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.